The role of endomyocardial biopsy (EMB) in the diagnosis and treatment of adult and pediatric cardiovascular disease remains controversial, and the practice varies widely even among cardiovascular centers of excellence. A need for EMB exists because specific myocardial disorders that have unique prognoses and treatment are seldom diagnosed by noninvasive testing.1 Informed clinical decision making that weighs the risks of EMB against the incremental diagnostic, prognostic, and therapeutic value of the procedure is especially challenging for nonspecialists because the relevant published literature is usually cited according to specific cardiac diseases, which are only diagnosed after EMB

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology / Cooper, Lt; Baughman, Kl; Feldman, Am; Frustaci, Andrea; Jessup, M; Kuhl, U; Levine, Gn; Narula, J; Starling, Rc; Towbin, J; Virmani, R.. - In: CIRCULATION. - ISSN 0009-7322. - 116:(2007), pp. 2216-2233. [10.1161/CIRCULATIONAHA.107.186093]

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

FRUSTACI, ANDREA;
2007

Abstract

The role of endomyocardial biopsy (EMB) in the diagnosis and treatment of adult and pediatric cardiovascular disease remains controversial, and the practice varies widely even among cardiovascular centers of excellence. A need for EMB exists because specific myocardial disorders that have unique prognoses and treatment are seldom diagnosed by noninvasive testing.1 Informed clinical decision making that weighs the risks of EMB against the incremental diagnostic, prognostic, and therapeutic value of the procedure is especially challenging for nonspecialists because the relevant published literature is usually cited according to specific cardiac diseases, which are only diagnosed after EMB
2007
01 Pubblicazione su rivista::01a Articolo in rivista
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology / Cooper, Lt; Baughman, Kl; Feldman, Am; Frustaci, Andrea; Jessup, M; Kuhl, U; Levine, Gn; Narula, J; Starling, Rc; Towbin, J; Virmani, R.. - In: CIRCULATION. - ISSN 0009-7322. - 116:(2007), pp. 2216-2233. [10.1161/CIRCULATIONAHA.107.186093]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/83493
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 188
  • Scopus 624
  • ???jsp.display-item.citation.isi??? 582
social impact